Loading clinical trials...

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients | Clinical Trials | Clareo Health

UNKNOWN

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients

Pilot Study to Compare the Humphrey Field Analyzer (HFA) 30-2 Swedish Interactive Threshold Algorithm (SITA) Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE), Using a New Fast GATE (German Adaptive Threshold Estimation) in Glaucoma Patients Under Topic Therapy

NCT00902109•University Hospital Tuebingen

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare the two psychophysical perimetric techniques regarding progression of the visual field.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•primary open angle glaucoma (POAG)
•spherical ametropia max. ± 8 dpt
•cylindrical ametropia max. ± 3 dpt
•distant visual acuity \> 10/20
•pupil diameter \> 3 mm

Exclusion Criteria

•diabetic retinopathy
•asthma
•history of epilepsy or significant psychiatric disease
•medications known to effect visual field sensitivity
•infections (e.g., keratitis, conjunctivitis, uveitis)
•severe dry eyes
•miotic drug
•squint
•nystagmus
•albinism
+5 more criteria

Locations (1)

Institute for Ophthalmic Research

Tübingen, Germany

Key Dates

Start Date

April 1, 2010

Primary Completion Date

December 1, 2016

Completion Date

December 1, 2016

Last Updated

February 2, 2016

Enrollment

ESTIMATED participants

Conditions

Primary Open Angle Glaucoma (POAG)

Interventions

Perimetry

DEVICE

Confocal Scanning Laser Tomography

DEVICE

Optical Coherence Tomography (OCT)

DEVICE

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01252849

Primary Open Angle Glaucoma (POAG)

View study

COMPLETEDNA

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

NCT01085357

Primary Open Angle Glaucoma (POAG)Cataract

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients

Inclusion Criteria

Exclusion Criteria

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy